Skip to main content
. 2019 May 24;7(2):44. doi: 10.3390/vaccines7020044

Figure A1.

Figure A1

EBNA1vax contains deleted regions of glycine-arginine and glycine-alanine repeats marked by Δ (12 and 310 amino acid deletions) and has its DNA-binding domain highlighted. LMP1vax and LMP2Avax have their cytoplasmic, extracellular, and transmembrane regions indicated. Modifications to engineer LMP2Avax derivatives are labeled as well.